XML 74 R64.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 8.9 $ 1.9 $ 17.9 $ 9.4
Cost of molecular diagnostic testing        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.4 0.3 0.7 0.7
Cost of pharmaceutical and clinical services        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 0.0 0.1 0.1 0.2
Research and development expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense 1.0 1.2 2.5 2.3
Selling, general, and administrative expense        
Share-Based Compensation Expense [Line Items]        
Total stock-based compensation expense $ 7.5 $ 0.3 $ 14.6 $ 6.2